Opinion | Pfizer’s pursuit of AstraZeneca: the Algerian scientific community should take note
Over the last few weeks, the biggest story in the pharmaceutical and biotechnology sectors has largely been that of Pfizer’s chase of AstraZeneca. In fact, Pfizer, one of the largest American pharmaceutical companies, continuous attempts to buy AstraZeneca, one of the largest UK pharmaceutical companies, has attracted a lot of interests from politicians in both sides of the Atlantic. Leaving the politics of this story aside, the scientific community in UK has been rattled by this story and this is what the Algerian scientific community should learn from. Read More
Opinion | Prospects for an Algerian academy of science and technology by 2014
There is no doubt that science is a crucial driver of social and economic development. Scientists therefore have a duty to both inform the general public about how findings from science can benefit day to day activities, and to direct the best of their efforts towards addressing national and international problems. Science academies can play an important role in empowering scientists to help them realise this duty because they provide a framework through which scientists can corroborate and channel their efforts. They act as collective hubs to organise scientific endeavour as well as motivate, support and reward excellence in scientific research. Read More